v3.26.1
Goodwill and Intangible Assets
12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets  
Goodwill and Intangible Assets

Note 7 – Goodwill, net and Intangible Assets, net

The Company’s intangible assets, net as of December 31, 2025 and December 31, 2024 consists of the following (in thousands):

Successor

December 31, 2025

  ​ ​ ​

Useful Life (years)

  ​ ​ ​

Gross Carrying Amount

  ​ ​ ​

Accumulated Amortization

  ​ ​ ​

Net Carrying Amount

IPR&D

Indefinite

$

6,969

$

$

6,969

Total

$

6,969

$

$

6,969

Successor

December 31, 2024

  ​ ​ ​

Useful Life (years)

  ​ ​ ​

Gross Carrying Amount

  ​ ​ ​

Accumulated Amortization

  ​ ​ ​

Impairment

Net Carrying Amount

IPR&D

Indefinite

$

22,100

$

$

(15,131)

$

6,969

Developed technology

5.0

4,100

(353)

 

(3,747)

Total

$

26,200

$

(353)

$

(18,878)

$

6,969

There was no amortization of intangible assets for the year ended December 31, 2025 (Successor).

For the period from January 1, 2024 to July 30, 2024 (Predecessor), the Company performed a qualitative assessment of its indefinite-lived intangible assets for impairment and determined that no indicators of impairment were present. Based on this assessment, the Company concluded that it was not more likely than not that the fair value of the indefinite-lived intangible assets was less than their carrying amounts. Accordingly, no quantitative impairment testing was required. No impairment charges related to indefinite-lived intangible assets were recorded during the period from January 1, 2024 to July 30, 2024 (Predecessor).

During the fourth quarter of 2024, the Company performed an impairment assessment on its indefinite lived intangible assets, and determined that as of December 31, 2024, the fair value of its intangible assets was less than the carrying amount. As a result, the Company recorded an $18.9 million impairment charge during the period from July 31, 2024, to December 31, 2024 (Successor). The impairment was driven by a sustained decline in the Company’s share price and market capitalization.

During the year ended December 31, 2025 (Successor), the Company performed a qualitative assessment of its indefinite-lived intangible assets for impairment and determined that no indicators of impairment were present. Based on this assessment, the Company concluded that it was not more likely than not that the fair value of the indefinite-lived intangible assets was less than their carrying amounts. Accordingly, no quantitative impairment testing was required. No impairment charges related to indefinite-lived intangible assets were recorded during the year ended December 31, 2025 (Successor).

The following table presents the changes in goodwill (in thousands):

Successor

December 31, 2025

Carrying Amount

  ​ ​ ​

Impairment

Net Carrying Amount

Goodwill

$

13,967

$

$

13,967

Successor

December 31, 2024

Carrying Amount

  ​ ​ ​

Impairment

Net Carrying Amount

Goodwill

$

44,291

$

(30,324)

$

13,967

For the period from January 1, 2024 to July 30, 2024 (Predecessor), the Company performed a qualitative assessment of goodwill for impairment and determined that no indicators of impairment were present. Based on this assessment, the Company concluded that it was not more likely than not that the fair value of the reporting unit was less than its carrying amount. Accordingly, no quantitative impairment testing was required. No impairment charges related to goodwill were recorded during the period from January 1, 2024 to July 30, 2024 (Predecessor).

During the fourth quarter of 2024, the Company conducted its annual assessment of goodwill. During its assessment, the Company determined that as of December 31, 2024, its fair value was less than the carrying amount. As a result, the Company recorded a $30.3 million goodwill impairment charge during the period from July 31, 2024, to December 31, 2024 (Successor). The impairment was driven by a sustained decline in the Company’s share price and market capitalization.

During the year ended December 31, 2025, the Company performed a qualitative assessment of goodwill for impairment and determined that no indicators of impairment were present. Based on this assessment, the Company concluded that it was not more likely than not that the fair value of the reporting unit was less than its carrying amount. Accordingly, no quantitative impairment testing was required. No impairment charges related to goodwill were recorded during the year ended December 31, 2025 (Successor).